- Trial practice focusing on complex civil litigation, including business litigation, financial litigation, personal injury and products liability mass tort.
- Represent individuals and families who have been injured by the pharmaceutical and medical device industry.
- Co-Chair, American Association for Justice Stockert 3T Heater-Cooler Litigation Group
- Plaintiffs' Steering Committee, Zofran Multi-District Litigation
- Discovery Committee and Law and Briefing Committee, Chantix Multi-District Litigation.
- Law and Briefing Committee, DePuy ASR Multi-District Litigation.
- Discovery Committee, DePuy Pinnacle Multi-District Litigation.
- Active pro bono volunteer in cases involving child protection and children seeking asylum.
- Judicial Extern to the Honorable Ann Montgomery, United States District Court (Fall 2003).
- Legal Writing Instructor, University of Minnesota (2002-2004).
Lead the firm’s litigation representing 100+ individuals harmed by the recalled DePuy ASR hip implant. Two nationwide settlements reached thus far in the DePuy Orthopaedics, Inc, ASR Hip Implant Products Liability Litigation (MDL 2197): one in November 2013 valued at approximately $2.5 billion and another in March 2015 valued at approximately $420 million. Litigation ongoing.
Represented 14-year-old child in deportation proceedings. Obtained T-Visa, designed for victims of severe forms of human trafficking, in 2016. Only about 500 T-Visas are granted annually.
Howerton v. Cargill, Inc. (D. Haw.): Representing Cargill, Incorporated in putative nationwide false-advertising class action concerning allegedly deceptive “natural” food labeling. Class settlement approved 2014.
Argued appeal upholding trial court's decision on jurisdiction and on vacating a transfer order, In re Welfare of Children of R.A.J., 769 N.W. 2d 297 (Minn. Ct. App. July 21, 2009).
Member of trial team in Charbonneau v. Boehringer Ingelheim Pharmaceuticals, Inc. and Pfizer, Inc.. Represented plaintiffs in first Mirapex products liability bellwether trial. On July 30, 2008, jury returned a verdict in favor of plaintiffs for $8,279,300, including $7.8 million in punitive damages for failing to warn of risk of compulsive behaviors, including pathological gambling, from the Parkinson's drug Mirapex.
Member of trial team in Zwayer v. Boehringer Ingelheim Pharmaceuticals, Inc. and Pfizer, Inc.. Represented plaintiffs in second Mirapex bellwether trial. Case was confidentially settled prior to closing argument.
- Minnesota Justice Foundation, Board Member (2006-present)
- University of Minnesota Law School, Alumni Relations and Annual Giving Committee (2006-present)
- Friends of the Mississippi River, Board Member (2000-2008)
- Children's Law Center, Pro Bono Attorney
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.